MedPath

Determining Baseline Respiratory Duty Cycles in Subjects With and Without Airway Hyperresponsiveness

Not Applicable
Completed
Conditions
Airway Hyper Responsiveness
Interventions
Procedure: Volumetric methacholine challenge unmodified
Procedure: Modified volumetric methacholine challenge
Registration Number
NCT04001465
Lead Sponsor
University of Saskatchewan
Brief Summary

The study investigates the inspiratory duty cycle in subjects with and without airway hyper-responsiveness both at rest and during a bronchoprovocation challenge. The primary goal is to determine an average inspiratory duty cycle for standard use in the calculation of bronchoprovocation test results.

Detailed Description

At least fifteen subjects with airway hyper-responsiveness and fifteen without airway hyper-responsiveness will be recruited to participate in this randomized, crossover study. Subjects will complete 2 methacholine challenges at least 24 hours apart. One methacholine challenge will entail the volumetric method using a vibrating mesh nebulizer. The second methacholine challenge will be performed identically except that the nebulizer will be fitted onto an ultrasonic nebulizer so as to measure the inspiratory duty cycle throughout the bronchoprovocation challenge.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Must be 18 years of age or older
  • Participants with airway hyper-responsiveness must have a positive methacholine challenge
  • Forced expiratory volume (FEV1) of at least 65% of predicted (based on age, height, and gender)
  • Participants without airway hyper-responsiveness must have a negative methacholine challenge
  • All participants must avoid strenuous exercise on test days
  • No short-acting beta-2 agonist use within 6 hours of study visit
Exclusion Criteria
  • Participants without known airway hyper-responsiveness cannot have a current or historical respiratory condition (e.g. asthma, allergic rhinitis)
  • Participants cannot be taking long-acting bronchodilators
  • Participants cannot be pregnant or lactating
  • Participants cannot have cardiovascular problems

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Volumetric methacholine challengeVolumetric methacholine challenge unmodifiedMethacholine challenge performed per the volumetric method using an Aerogen Solo vibrating mesh nebulizer
Methacholine challenge with spirometerModified volumetric methacholine challengeMethacholine challenge performed per the volumetric method using an Aerogen Solo vibrating mesh nebulizer fitted with an ultrasonic spirometer
Primary Outcome Measures
NameTimeMethod
Average inspiratory duty cycle in subjects without airway hyper-responsiveness24 hours

The inspiratory duty cycles measured for each participant (in duplicate over at least 24 hours) will be averaged for all participants without airway hyper-responsiveness

Average inspiratory duty cycle in subjects with airway hyper-responsiveness measured using ultrasonic spirometer and tidal breathing24 hours

The inspiratory duty cycles measured for each participant (in duplicate over at least 24 hours) will be averaged for all participants with airway hyper-responsiveness and for all participants without airway-hyperresponsiveness

Secondary Outcome Measures
NameTimeMethod
Between-subject variability within subject group (i.e. airway hyper-responsiveness group)1 hour

Investigation of whether subjects differ in their inspiratory duty cycles (within their respective study group)

Within-subject variability in provocative dose of methacholine causing a 20% fall in forced expiratory volume (PD20) between repeat methacholine challenges24 hours

Repeat PD20 measures collected for each participant will be compared to determine if there is any significant within-subject variability in PD20

Within-subject variability in inspiratory duty cycle measured using ultrasonic spirometer and tidal breathing during room air inhalation24 hours

Repeat measurements of inspiratory duty cycle during tidal breathing of room air collected at least 24 hours apart

Variability in in inspiratory duty cycle between airway hyper-responsiveness group and group without airway-hyperresponsiveness1 hour

Analysis of variance to determine whether subjects differ in their inspiratory duty cycles based on their status as having or as not having airway-hyperresponsiveness

Within-subject variability in inspiratory duty cycle measured using ultrasonic spirometer and tidal breathing during saline inhalation24 hours

Repeat measurements of inspiratory duty cycle during tidal breathing of nebulized saline collected at least 24 hours apart

Variability in inspiratory duty cycle within subjects when inhaling room air versus an aerosol while using tidal breathing through an ultrasonic spirometer1 hour

Investigation of whether participants differ in their inspiratory duty cycle when inhaling room air versus a saline vapor (i.e. does an aerosol influence people's breathing pattern)

Variability in inspiratory duty cycle with progressive airway constriction induced through methacholine challenge testing24 hours

The inspiratory duty cycle in each subject will be measured throughout a methacholine challenge during each inhalation period, which will allow for determination of whether the inspiratory duty cycle changes with the progressive airway constriction (or lack thereof) induced through methacholine challenge testing

Between-subject variability within subject group (no airway hyper-responsiveness group)1 hour

Investigation of whether subjects differ in their inspiratory duty cycles (within their respective study group)

Trial Locations

Locations (1)

Asthma Research Lab - University of Saskatchewan

🇨🇦

Saskatoon, Saskatchewan, Canada

© Copyright 2025. All Rights Reserved by MedPath